How does Flash Glucose Monitoring affect Blood Glucose Levels of Indigenous Australians with type 2 diabetes?- A Pilot Study.

Not Applicable

Completed

• Conditions: Diabetes; type 2 diabetes; Metabolic and Endocrine - Diabetes

• Registration Number: ACTRN12621000021875
• Lead Sponsor: niversity of Melbourne

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-01-14
• Study Completion: 2022-05-05
• Last Update Posted: 13 June 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Indigenous Australians with type 2 diabetes and HbA1c greater than or equal to 7.0% (53mmol/L) AND one of the following:
-Injectable therapy (including insulin) ± oral hypoglycaemic agent, or
-GLP-1 analogue ± oral hypoglycaemia agent, or
-GLP-1 analogue and insulin ± oral hypoglycaemic agent

Exclusion Criteria

Any of the following:
-Age < 18 years
-Type 1 diabetes mellitus
-Active illicit drug use or heavy alcohol use (> 4 standard drinks/day)
-Active malignancy
-Known allergy to medical-grade adhesives
-On varying doses of corticosteroid therapy
-Using amphetamines, anabolic or weight-reducing medications
-Pregnancy or actively planning pregnancy
-eGFR<15ml/min/1.732 or erythropoiesis stimulating agents or end-stage kidney disease
-Haemoglobinopathies.

Study & Design

• Study Type: Interventional
• Study Design: Not specified